Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

UMR Statement on Passage of FY22 Omnibus

March 11, 2022

United for Medical Research is very pleased with passage of the omnibus spending package Thursday night that provides $45 billion for the National Institutes of Health, an increase of $2.25 billion.  Once again, Senators Patty Murray (D-WA) and Roy Blunt (R-MO), and Reps. Rosa DeLauro (D-CT) and Tom Cole (R-OK) have led the charge to boost NIH funding, and the members of UMR are extremely grateful.  Their ongoing bipartisan commitment toward sustainable funding of biomedical research is saving​ lives and providing hope for patients and families awaiting new treatments and cures.

In addition, we are pleased to see Congress’ commitment to accelerating the pace of scientific breakthroughs for diseases such as ALS, Alzheimer’s, diabetes, and cancer through its investment of $1 billion to establish the Advance Research Projects Agency for Health (ARPA-H) within the HHS Office of the Secretary.

UMR is a coalition of leading research institutions, patient and health advocates and private industry seeking steady and sustainable increases in funding for the National Institutes of Health in order to save and improve lives, advance innovation and fuel the economy.